FDA crackdown targets unpublished research results
(The Center Square) – The U.S. Food and Drug Administration issued more than 2,200 notices urging companies and researchers to comply with federal publication rules.
A recent FDA crackdown highlights transparency issues in clinical research, as thousands of companies and researchers have failed to disclose required trial results. Some
